跳至主要内容
临床试验/ACTRN12613000751774
ACTRN12613000751774尚未招募4 期

In children with inflammatory bowel disease and iron deficiency, does intravenous iron therapy with Ferric Carboxymaltose signficantly improve cognitive function, quality of life and iron status.

Gastroenterology Department, Royal Children's Hospital - Brisbane0 个研究点目标入组 50 人开始时间: 2013年7月5日最近更新:
适应症

试验速览

阶段
4 期
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Non-randomised trial
主要目的
Treatment

入排标准

年龄范围
6 Years 至 18 Years(—)
性别
All

入选标准

  • Paediatric patients with documented inflammatory bowel disease (Crohn's disease or Ulcerative colitis) being treated at the Royal Children's Hospital, with iron deficiency as defined by international criteria (ferritin less than 30, TS less than 16% or ferritin less than 100 with coexisting inflammation)

排除标准

  • Patients will be excluded if:
  • 1 - They have a haemoglobinopathy
  • 2 - They received a blood transfusion in the previous 6 weeks
  • 3 - Patient or family do not give consent for participation in the study
  • 4 - They have advanced liver disease
  • 5 - They have acute severe colitis

研究者

发起方
Gastroenterology Department, Royal Children's Hospital - Brisbane

相似试验

In children with inflammatory bowel disease and iron... | 临床试验